DermTest Company

Dermtest is a doctor-to-doctor telemedicine platform empowering family doctors to provide high quality skin-cancer early detection service. Dermtest enables discovering early changes in moles that may develop into malignant skin tumors. The system combines teledermatology software and diagnostic hardware into a complete solution, including telemedicine, m-health and personalized medicine components. The core of the Dermtest product is a teledermoscopy system with decision support, connecting family doctors with dermatologists for providing access to a dermatologist consultation at a patient’s local primary care clinic.
Technology: TeleHealth
Industry: AgeTech
Headquarters: Europe
Founded Date: 2013-01-01
Employees Number: 1-10
Funding Status: Seed
Investors Number: 4
Total Funding: $441K
Estimated Revenue: Less than $1M
Last Funding Type: Grant

Visit Website
Register and Claim Ownership